drug

L-Arginine

L-arginine
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hacettepe University
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

3
L-arginine Study for Persistent Symptoms of Schizophrenia
NCT04054973Phase 2Withdrawn
L-arginine add-on Therapy in Patients With Schizophrenia
NCT02398279—Completed
L-arginine in Treatment as Usual in Schizophrenia
NCT00718510—Completed

KOLs & investigators

9
Xiaoduo Fan, MD, MPH, MSKOL score 9
John W. Newcomer, M.D.KOL score 5
Pierre Flor-Henry, F.R.C.P.C.
Mee-Sook Song, Ph.D.
Glen Baker, Ph.D., D.Sc.
Kazım M Yazıcı, MD
Serdar Dursun, M.D., Ph.D.
Diane Cox, Ph.D.
Phil Tibbo, F.R.C.P.C.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Hacettepe University
company
trial
L-arginine Study for Persistent Symptoms of Schizophrenia
PHASE2
trial
L-arginine add-on Therapy in Patients With Schizophrenia
NA
trial
L-arginine in Treatment as Usual in Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizo Affective Disorder
indication
Schizophrenia
indication
Psychotic Disorders
indication
KOL
Xiaoduo Fan, MD, MPH, MS
KOL score 9
person
John W. Newcomer, M.D.
KOL score 5
person
Pierre Flor-Henry, F.R.C.P.C.
KOL score —
person
Mee-Sook Song, Ph.D.
KOL score —
person